HPQ
HP Inc.
HPQ's fundamentals are mixed, but it looks expensive: trading at 11x earnings, above its usual 9.8x. Analysts expect earnings growth.
HPQ Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Healthy | |
| Healthy |
HPQ's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
HPQ PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.3x | $19.05 | -34% |
| Forward | 9.3x | $28.88 | — |
| Fair | 9.8x | $25.65 | -11% |
| Current | 11x | $28.88 | — |
| Expensive | 12x | $31.53 | +9.2% |
Historical ranges are pointers, not guarantees.
HPQ's PE is in its expensive range at 11x. If earnings grow as analysts expect, today's price would be 9.3x next year's earnings, in its fair range.
HPQ Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect HPQ's earnings to grow, with its revenue and profitability holding steady.
HPQ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.11 | +19% |
| Q3 2026 | $2.62 | -4.4% |
| Q2 2026 | $2.71 | +4.6% |
| Q1 2026 | $2.64 | -5% |
| Q4 2025 | $2.65 | -5.7% |
| Q3 2025 | $2.74 | -3.9% |
| Q2 2025 | $2.59 | -13% |
| Q1 2025 | $2.78 | -19% |
| Q4 2024 | $2.81 | -15% |
HPQ's earnings per share have fallen from their peak: $2.62 over the past year, against $5.61 in mid-2022.
HPQ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $15.7B | +13% |
| Q2 2026 | $14.4B | +9% |
| Q1 2026 | $14.4B | +6.9% |
| Q4 2025 | $14.6B | +4.2% |
| Q3 2025 | $13.9B | +3.1% |
| Q2 2025 | $13.2B | +3.3% |
| Q1 2025 | $13.5B | +2.4% |
| Q4 2024 | $14.1B | +1.7% |
HPQ's revenue has grown year over year for nine quarters in a row: $15.7B last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.7% | +0.6 points |
| Q2 2026 | 4.3% | -0.7 points |
| Q1 2026 | 5.3% | -1 points |
| Q4 2025 | 6.5% | -0.5 points |
| Q3 2025 | 5.1% | -1.8 points |
| Q2 2025 | 5% | -2.5 points |
| Q1 2025 | 6.3% | -0.8 points |
| Q4 2024 | 7% | -0.3 points |
HPQ's operating margin was 5.7% last quarter, up 0.6 points from the same quarter a year ago.
HPQ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | +7.1% |
| Q2 2026 | $756M | +$901M |
| Q1 2026 | $150M | +108% |
| Q4 2025 | $1.4B | -2.9% |
| Q3 2025 | $1.4B | +15% |
| Q2 2025 | -$145M | -131% |
| Q1 2025 | $72M | +$109M |
| Q4 2024 | $1.5B | -19% |
HPQ still generates free cash flow, though less than at its 2021 peak: $3.9B over the past year.
HPQ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +2M shares |
| 1 year | -2.8% | -27M shares |
| 3 years | -7.5% | -75M shares |
| 5 years | -23% | -272M shares |
| Available history | -39% | -597M shares |
HPQ has 927M diluted shares, down 2.8% from a year ago, with $1.2B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300M |
| Q2 2026 | $100M |
| Q1 2026 | $325M |
| Q4 2025 | $500M |
| Q3 2025 | $200M |
| Q2 2025 | $100M |
| Q1 2025 | $100M |
| Q4 2024 | $900M |
HPQ spent $1.2B buying back its own shares over the past year, down 5.8% from the year before.
HPQ Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 1.6x | Healthy |
| Q4 2025 | 1.5x | Healthy |
| Q3 2025 | 1.6x | Healthy |
| Q2 2025 | 1.9x | Healthy |
| Q1 2025 | 1.5x | Healthy |
| Q4 2024 | 1.4x | Healthy |
HPQ's net debt is about 1.2 years of its operating earnings (EBITDA), down from 1.6 years a year ago.
HPQ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.2 | Neutral |
| Stochastic | 23.8 | Neutral |
HPQ's weekly RSI is 51 (neutral) and its Stochastic is 24 (neutral).
HPQ PE vs Technology Sector
| Metric | HPQ | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 60% below |
| PE % | 69 | 35 | 34 pts above |
HPQ is trading at 11x earnings, a 60% discount to the Technology sector's median of 28x.
HPQ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $30.4 | 5.1% below |
| 20 week MA | $29.5 | 2.2% below |
| 50 week MA | $24.7 | 17% above |
| 100 week MA | $26.2 | 10% above |
| 200 week MA | $28.8 | 0.5% above |
HPQ has slipped below its 8- and 20-week averages, though it's still 0.5% above its 200-week average.
HPQ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $20.5 | $24.3 | +18% |
| 2021 | $24.3 | $37.7 | +55% |
| 2022 | $37.7 | $26.8 | -29% |
| 2023 | $26.8 | $30.1 | +12% |
| 2024 | $30.1 | $33.3 | +11% |
| 2025 | $33.3 | $23.3 | -30% |
| 2026 YTD | $23.3 | $28.9 | +24% |
HPQ has finished higher in four of the last six years. It's up 24% so far in 2026.